• Users Online: 933
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of Mycobacterium tuberculosis

Narang Anshika, Giri Astha, Gupta Shraddha, Garima Kushal, Bose Mridula, Varma-Basil Mandira

Year : 2017| Volume: 6| Issue : 2 | Page no: 177-183

   This article has been cited by
 
1 First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness
Flavio De Maio,Antonella Cingolani,Delia Mercedes Bianco,Alessandro Salustri,Ivana Palucci,Maurizio Sanguinetti,Giovanni Delogu,Michela Sali
International Journal of Medical Microbiology. 2021; 311(4): 151506
[Pubmed]  [Google Scholar] [DOI]
2 Effect of the deletion of lprG and p55 genes in the K10 strain of Mycobacterium avium subspecies paratuberculosis
Mariana Noelia Viale,María Alejandra Colombatti Olivieri,Natalia Alonso,Roberto Damián Moyano,Belén Imperiale,Nora Morcillo,María Paz Santangelo,William Davis,María Isabel Romano
Research in Veterinary Science. 2021; 138: 1
[Pubmed]  [Google Scholar] [DOI]
3 Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance
Mark Laws,Peiqin Jin,Khondaker Miraz Rahman
Trends in Microbiology. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens: a systematic review
Emmanuel Rivière,Michael G. Whitfield,Jochem Nelen,Tim H. Heupink,Annelies Van Rie
Clinical Microbiology and Infection. 2020;
[Pubmed]  [Google Scholar] [DOI]
5 Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates
Manaf AlMatar,Isil Var,Begüm Kayar,Fatih Köksal
Endocrine, Metabolic & Immune Disorders - Drug Targets. 2020; 20(2): 271
[Pubmed]  [Google Scholar] [DOI]
6 Differential Isoniazid Response Pattern Between Active and Dormant Mycobacterium tuberculosis
M.A. Abo-Kadoum,Yongdong Dai,Mohammed Asaad,Insaf Hamdi,Jianping Xie
Microbial Drug Resistance. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis
Siavash J. Valafar
Antimicrobial Agents and Chemotherapy. 2020; 65(3)
[Pubmed]  [Google Scholar] [DOI]
8 Identification of Mutations Conferring Tryptanthrin Resistance to Mycobacterium smegmatis
Svetlana G. Frolova,Ksenia M. Klimina,Ravinder Kumar,Aleksey A. Vatlin,Deepak B. Salunke,Pravin Kendrekar,Valery N. Danilenko,Dmitry A. Maslov
Antibiotics. 2020; 10(1): 6
[Pubmed]  [Google Scholar] [DOI]
9 Genome-Wide Transcriptional Responses of Mycobacterium to Antibiotics
Julien Briffotaux,Shengyuan Liu,Brigitte Gicquel
Frontiers in Microbiology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
10 Possible Binding of Piperine in Mycobacterium tuberculosis RNA Polymerase and Rifampin Synergism
Letícia Sayuri Murase,João Vítor Perez de Souza,Jean Eduardo Meneguello,Flavio Augusto Vicente Seixas,Laíse Adriane Hegeto,Regiane Bertin de Lima Scodro,Vera Lucia Dias Siqueira,Katiany Rizzieri Caleffi Ferracioli,Rosilene Fressatti Cardoso
Antimicrobial Agents and Chemotherapy. 2019; 63(11)
[Pubmed]  [Google Scholar] [DOI]
11 Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents
Ashutosh Prasad Tiwari,B. Sridhar,Helena I. Boshoff,Kriti Arora,G. Gautham Shenoy,K. E. Vandana,G. Varadaraj Bhat
Molecular Diversity. 2019;
[Pubmed]  [Google Scholar] [DOI]
12 Recent updates on drug resistance in Mycobacterium tuberculosis
R. Singh,S.P. Dwivedi,U.S. Gaharwar,R. Meena,P. Rajamani,T. Prasad
Journal of Applied Microbiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
13 Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps
Hasan Ghajavand,Mansour Kargarpour Kamakoli,Sharareh Khanipour,Shahin Pourazar Dizaji,Morteza Masoumi,Fatemeh Rahimi Jamnani,Abolfazl Fateh,Mehdi Yaseri,Seyed Davar Siadat,Farzam Vaziri
Antimicrobial Resistance & Infection Control. 2019; 8(1)
[Pubmed]  [Google Scholar] [DOI]
14 Altered drug efflux under iron deprivation unveils abrogated MmpL3 driven mycolic acid transport and fluidity in mycobacteria
Rahul Pal,Saif Hameed,Zeeshan Fatima
BioMetals. 2018;
[Pubmed]  [Google Scholar] [DOI]
15 Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain
Angkanang Sowajassatakul,Therdsak Prammananan,Angkana Chaiprasert,Saranya Phunpruch
Annals of Clinical Microbiology and Antimicrobials. 2018; 17(1)
[Pubmed]  [Google Scholar] [DOI]
16 Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne’s model of dormancy
Sajith Raghunandanan,Leny Jose,Ramakrishnan Ajay Kumar
The Journal of Antibiotics. 2018;
[Pubmed]  [Google Scholar] [DOI]
17 Genetic diversity of Mycobacterium tuberculosis and transmission associated with first-line drug resistance: a first analysis in Jalisco, Mexico
Gladys Lopez-Avalos,Guadalupe Gonzalez-Palomar,Martín Lopez-Rodriguez,Carlos Arturo Vazquez-Chacon,Gustavo Mora-Aguilera,Juan Antonio Gonzalez-Barrios,Juan Carlos Villanueva-Arias,Manuel Sandoval-Diaz,Ulises Miranda-Hernández,Ikuri Alvarez-Maya
Journal of Global Antimicrobial Resistance. 2017; 11: 90
[Pubmed]  [Google Scholar] [DOI]

 

Read this article